- $65.64m
- $51.26m
- $54.40m
- 80
- 49
- 80
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32.8 | 45.1 | 27.4 | 30.6 | 54.4 |
Cost of Revenue | |||||
Gross Profit | 6.59 | 6.8 | 6.36 | 8.98 | 11 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 32.3 | 44.6 | 28.2 | 29.7 | 52.6 |
Operating Profit | 0.48 | 0.496 | -0.831 | 0.914 | 1.75 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.167 | 0.129 | -1.23 | -0.017 | 0.134 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.126 | 0.079 | -1.3 | -0.073 | 0.074 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.126 | 0.079 | -1.3 | -0.073 | 0.074 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.126 | 0.079 | -1.3 | -0.073 | 0.074 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.007 | -0.024 | -0.071 | -0.004 | 0.003 |